ACADIA Pharmaceuticals Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
ABBV | AbbVie | Outperform |
9
|
$162.55 | $178.42 | 10.74% | 11 | $287.04B |
AMGN | Amgen | Outperform |
4
|
$300.30 | $303.65 | 6.56% | 8 | $161.09B |
GILD | Gilead Sciences Inc | Outperform |
11
|
$65.46 | $87.82 | 22.21% | 14 | $81.63B |
ALXN | Alexion Pharmaceuticals | - |
0
|
$182.50 | $177.38 | -100.00% | 0 | $40.34B |
BIIB | Biogen | Outperform |
10
|
$218.92 | $299.62 | 31.78% | 13 | $31.87B |
BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$82.58 | $111.56 | 33.20% | 5 | $15.68B |
INCY | Incyte | Outperform |
9
|
$54.37 | $77.05 | 44.38% | 8 | $11.89B |
VKTX | Viking Therapeutics | Buy |
5
|
$79.61 | $34.00 | 44.45% | 6 | $8.78B |
BPMC | Blueprint Medicines | Outperform |
6
|
$108.55 | $85.71 | 10.09% | 5 | $6.71B |
ARNA | Arena Pharmaceuticals | - |
6
|
$99.99 | $100.00 | -100.00% | 0 | $6.17B |
CCXI | ChemoCentryx | - |
8
|
$51.99 | $52.00 | -100.00% | 0 | $3.74B |
CBAY | CymaBay Therapeutics | Hold |
8
|
$32.44 | $27.73 | -100.00% | 5 | $3.72B |
IOVA | Iovance Biotherapeutics | Buy |
4
|
$13.98 | $20.42 | 82.40% | 4 | $3.30B |
ARWR | Arrowhead Pharmaceuticals | Outperform |
7
|
$25.00 | $52.00 | 120.00% | 0 | $2.99B |
DRNA | Dicerna Pharmaceuticals | - |
7
|
$38.01 | $35.06 | -100.00% | 0 | $2.99B |
FOLD | Amicus Therapeutics | Outperform |
7
|
$10.42 | $17.90 | 91.94% | 1 | $2.96B |
CLDX | Celldex Therapeutics | Buy |
11
|
$42.21 | $63.29 | 68.21% | 1 | $2.81B |
VCEL | Vericel | Buy |
8
|
$49.52 | $42.58 | 11.07% | 0 | $2.22B |
ARDX | Ardelyx | Buy |
11
|
$9.31 | $9.94 | 50.38% | 5 | $2.04B |
AGIO | Agios Pharmaceuticals | Outperform |
9
|
$32.80 | $40.00 | 35.67% | 4 | $1.96B |
DVAX | Dynavax Technologies | Outperform |
11
|
$11.76 | $25.00 | 108.33% | 1 | $1.54B |
ADMA | ADMA Biologics | Buy |
9
|
$6.91 | $6.00 | 15.77% | 0 | $1.51B |
XNCR | Xencor | Outperform |
6
|
$24.24 | $37.91 | 40.26% | 4 | $1.50B |
MNKD | MannKind | Buy |
10
|
$4.47 | $6.92 | 51.01% | 1 | $1.11B |
BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$5.26 | $14.09 | 109.13% | 2 | $1.09B |
CATX | Perspective Therapeutics | Buy |
9
|
$1.84 | $1.20 | -13.04% | 0 | $986.02M |
OCUL | Ocular Therapeutix | Outperform |
6
|
$5.93 | $12.25 | 152.95% | 3 | $917.53M |
SAGE | Sage Therapeutics | Hold |
6
|
$12.98 | $25.28 | 46.38% | 2 | $838.94M |
BLFS | BioLife Solutions | Buy |
9
|
$18.60 | $22.57 | 15.59% | 1 | $794.56M |
ABUS | Arbutus Biopharma | Outperform |
9
|
$2.84 | $6.34 | 92.96% | 0 | $511.42M |
TVTX | Travere Therapeutics | Outperform |
8
|
$6.75 | $14.07 | 114.81% | 5 | $498.51M |
RDUS | Radius Health | - |
4
|
$10.08 | $10.00 | -100.00% | 0 | $485.05M |
FATE | Fate Therapeutics | Outperform |
7
|
$3.88 | $6.23 | 80.41% | 14 | $462.10M |
KIN | Kindred Biosciences | - |
7
|
$9.25 | $9.25 | 15.57% | 2 | $420.53M |
ANIK | Anika Therapeutics | Outperform |
10
|
$28.36 | $27.33 | 12.83% | 2 | $404.52M |
CRBP | Corbus Pharmaceuticals Holding... | Buy |
6
|
$39.77 | $20.00 | 70.98% | 3 | $389.19M |
RVNC | Revance Therapeutics | Outperform |
6
|
$4.38 | $26.92 | 219.63% | 5 | $376.22M |
HRTX | Heron Therapeutics | Buy |
7
|
$2.87 | $5.63 | 126.48% | 0 | $432.33M |
ENTA | Enanta Pharmaceuticals | Outperform |
10
|
$13.10 | $23.88 | 45.04% | 2 | $308.88M |
PFNX | Pfenex | - |
2
|
$0.00 | $13.00 | 0.00% | 0 | $301.67M |
CERS | Cerus | Outperform |
6
|
$1.85 | $4.13 | 170.27% | 1 | $299.52M |
CNCE | Concert Pharmaceuticals | - |
6
|
$8.37 | $17.00 | -100.00% | 0 | $293.84M |
CRMD | CorMedix | Outperform |
10
|
$5.84 | $14.25 | 105.48% | 0 | $288.93M |
VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$5.48 | $4.25 | -4.93% | 0 | $284.01M |
CDXS | Codexis | Buy |
6
|
$3.53 | $5.83 | 41.64% | 3 | $276.59M |
AKBA | Akebia Therapeutics | Outperform |
8
|
$1.40 | $4.33 | 257.14% | 2 | $263.81M |
EPZM | Epizyme | - |
6
|
$1.47 | $6.00 | -100.00% | 0 | $255.91M |
CHRS | Coherus BioSciences | Outperform |
6
|
$2.25 | $10.86 | 255.56% | 3 | $255.37M |
ALDX | Aldeyra Therapeutics | Buy |
7
|
$4.17 | $9.40 | 139.81% | 0 | $247.16M |
STML | Stemline Therapeutics | - |
7
|
$169.15 | $12.50 | -100.00% | 0 | $229.28M |
ADRO | Aduro Biotech | - |
6
|
$2.59k | $18.75 | -100.00% | 0 | $221.28M |
CLVS.Q | Clovis Oncology | - |
6
|
$0.02 | $1.50 | -100.00% | 0 | $208.62M |
ABEO | Abeona Therapeutics | Buy |
8
|
$4.56 | $21.25 | 272.81% | 2 | $207.08M |
OMER | Omeros | Hold |
11
|
$3.64 | $13.00 | -100.00% | 2 | $182.52M |
BLUE | bluebird bio | Hold |
6
|
$1.01 | $7.20 | 296.04% | 2 | $194.67M |
XOMA | XOMA | Outperform |
2
|
$23.13 | $74.00 | 219.93% | 0 | $169.90M |
LJPC | La Jolla Pharmaceutical | - |
11
|
$6.22 | $6.23 | -100.00% | 0 | $154.54M |
RGLS | Regulus Therapeutics | Outperform |
10
|
$2.23 | $7.67 | 236.32% | 3 | $139.44M |
ORMP | Oramed Pharmaceuticals | Hold |
8
|
$2.40 | $4.30 | 77.08% | 0 | $126.66M |
GLYC | GlycoMimetics | Buy |
10
|
$0.31 | $7.67 | -100.00% | 1 | $117.94M |
DMAC | DiaMedica Therapeutics | Buy |
2
|
$3.66 | $8.33 | 91.26% | 0 | $116.14M |
CLRB | Cellectar Biosciences | Buy |
6
|
$3.29 | $12.00 | 279.94% | 1 | $114.80M |
LIFE | aTyr Pharma | Outperform |
10
|
$1.70 | $26.00 | 1076.47% | 2 | $93.11M |
CMRX | Chimerix | Buy |
10
|
$0.99 | $7.33 | 607.07% | 4 | $85.41M |
MNOV | MediciNova | Buy |
4
|
$1.50 | $16.50 | 1000.00% | 0 | $80.44M |
MRNS | Marinus Pharmaceuticals | Outperform |
6
|
$1.57 | $20.30 | 282.17% | 1 | $77.44M |
ATRA | Atara Biotherapeutics | Hold |
5
|
$0.60 | $4.83 | 175.00% | 3 | $75.84M |
ASMB | Assembly Biosciences | Outperform |
11
|
$12.62 | $3.00 | 185.26% | 2 | $72.10M |
CDTX | Cidara Therapeutics | Buy |
6
|
$13.44 | $4.67 | 86.01% | 1 | $61.71M |
PTN | Palatin Technologies | Buy |
4
|
$2.08 | $43.00 | 188.46% | 0 | $56.60M |
SCYX | SCYNEXIS | Buy |
6
|
$1.85 | $7.13 | 264.86% | 2 | $54.37M |
CARA | Cara Therapeutics | Outperform |
6
|
$0.79 | $12.14 | 532.91% | 0 | $49.58M |
BCLI | Brainstorm Cell Therapeutics | Hold |
4
|
$0.37 | $0.50 | 575.68% | 0 | $36.36M |
NLTX | Neoleukin Therapeutics | - |
6
|
$13.96 | $21.57 | -100.00% | 0 | $31.01M |
V9Z | Aceragen | - |
7
|
0.47€ | 1.00€ | -100.00% | 0 | 25.39€M |
LSTA | Lisata Therapeutics | Buy |
8
|
$2.75 | $16.00 | 427.27% | 2 | $22.85M |
AYTU | Aytu BioPharma | Outperform |
9
|
$3.06 | $5.00 | 161.44% | 0 | $17.54M |
NERV | Minerva Neurosciences | Hold |
4
|
$2.49 | $11.00 | 181.12% | 1 | $17.34M |
ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
PIRS | Pieris Pharmaceuticals | - |
9
|
$11.04 | $7.00 | -100.00% | 0 | $14.35M |
TRVN | Trevena | Outperform |
2
|
$0.61 | $5.18 | 555.74% | 0 | $9.38M |
HEPA | Hepion Pharmaceuticals | Outperform |
7
|
$1.37 | $30.00 | 2089.78% | 0 | $7.50M |
PSTV | Plus Therapeutics | Buy |
11
|
$2.13 | $11.00 | 604.23% | 2 | $7.35M |
TENX | Tenax Therapeutics | Outperform |
4
|
$3.53 | $5.50 | 820.68% | 1 | $7.11M |
XBIO | Xenetic Biosciences | Hold |
8
|
$3.85 | $4.00 | 4.68% | 0 | $5.98M |
NHWK | NightHawk Biosciences | Hold |
8
|
$0.18 | $10.00 | -100.00% | 0 | $5.66M |
TCON | TRACON Pharmaceuticals | Outperform |
9
|
$1.82 | $4.00 | 1960.44% | 0 | $4.46M |
BPTH | Bio-Path Holdings | Outperform |
5
|
$3.00 | $12.00 | 1233.33% | 1 | $3.96M |
CYCC | Cyclacel Pharmaceuticals | Outperform |
5
|
$2.11 | $240.00 | 421.33% | 0 | $3.49M |
ARAV | Aravive | - |
10
|
$0.04 | $0.25 | -100.00% | 0 | $2.95M |
ADXS | Advaxis | - |
8
|
$0.80 | $2.25 | -100.00% | 0 | $2.45M |
ATHX | Athersys | - |
6
|
$0.00 | $5.50 | 0.00% | 1 | $0.87M |
BLCM | Bellicum Pharmaceuticals | - |
6
|
$0.06 | $5.00 | -100.00% | 0 | $0.77M |
BLPH | Bellerophon Therapeutics | - |
7
|
$0.06 | $2.00 | -50.00% | 0 | $0.40M |
CFRX.Q | ContraFect | - |
5
|
$0.02 | $7.00 | -50.00% | 0 | $0.32M |
CALA | Calithera Biosciences | - |
6
|
$0.02 | $7.71 | -100.00% | 1 | $0.10M |
GNCA.Q | Genocea Biosciences | - |
9
|
$0.00 | $6.00 | 0.00% | 0 | $0.00M |
XLRN | Acceleron Pharma | - |
0
|
$179.68 | $177.75 | -100.00% | 0 | $0.00M |
ONCS.Q | OncoSec Medical | - |
7
|
$0.00 | $110.00 | 0.00% | 0 | $0.00M |
AGTC | Beacon Therapeutics (USA) | - |
11
|
$0.39 | $0.37 | -100.00% | 1 | $0.00M |